04:56:26 EDT Thu 18 Apr 2024
Enter Symbol
or Name
USA
CA



News for C:SBM from 2023-04-19 to 2024-04-18 - 32 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-04-09 16:54C:SBMSirona Biochem Corp0.07Private PlacementSirona Biochem 1,325,000-share private placement
2024-04-08 11:03C:SBMSirona Biochem Corp0.065News ReleaseSirona Biochem reviews recent activities
2024-04-04 23:27C:SBMSirona Biochem Corp0.07News ReleaseSirona Biochem closes $132,500 private placement
2024-04-01 11:29C:SBMSirona Biochem Corp0.065SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-04-01 11:29C:SBMSirona Biochem Corp0.065SEDAR Interim MD & ASEDAR Interim MD & A
2024-03-28 16:53C:SBMSirona Biochem Corp0.065News ReleaseSirona Biochem shareholders approve all matters at AGM
2024-03-13 11:44C:SBMSirona Biochem Corp0.08News ReleaseSirona receives GlycoProteMim-based serum formulations
2024-02-28 19:03C:SBMSirona Biochem Corp0.09SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-02-28 19:03C:SBMSirona Biochem Corp0.09SEDAR MD & ASEDAR MD & A
2024-02-16 19:19C:SBMSirona Biochem Corp0.105MiscellaneousSirona Biochem 450,000 bonus shares
2024-02-15 18:07C:SBMSirona Biochem Corp0.10News ReleaseSirona Biochem amends promissory note
2024-02-15 13:10C:SBMSirona Biochem Corp0.09News ReleaseSirona Biochem forms partnership with Global Beauty
2024-01-29 11:21C:SBMSirona Biochem Corp0.10News ReleaseSirona Biochem arranges $1-million loan
2024-01-26 18:24C:SBMSirona Biochem Corp0.10News ReleaseSirona Biochem arranges $1-million private placement
2024-01-24 01:59C:SBMSirona Biochem Corp0.11Shareholders LetterSirona Biochem to manufacture GlycoProteMim on request
2024-01-15 01:57C:SBMSirona Biochem Corp0.115News ReleaseSirona Biochem creates Sirona Laboratories subsidiary
2023-12-11 09:44C:SBMSirona Biochem Corp0.08News ReleaseSirona Biochem begins trademark process for TFC-1326
2023-11-29 16:14C:SBMSirona Biochem Corp0.085News ReleaseSirona finds four compounds show anti-viral activity
2023-10-25 18:38C:SBMSirona Biochem Corp0.075News ReleaseSirona changes auditor to Davidson & Company
2023-10-24 19:22C:SBMSirona Biochem Corp0.075Shares for DebtSirona Biochem 1,380,979 shares for debt
2023-10-20 16:55C:SBMSirona Biochem Corp0.09News ReleaseSirona Biochem to issue 1.3M shares as interest payment
2023-09-29 14:20C:SBMSirona Biochem Corp0.105SEDAR Interim MD & ASEDAR Interim MD & A
2023-09-29 14:17C:SBMSirona Biochem Corp0.105SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-07-20 22:40C:SBMSirona Biochem Corp0.115SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-07-13 14:52C:SBMSirona Biochem Corp0.135Shareholders LetterSirona Biochem completes review of business
2023-06-29 16:55C:SBMSirona Biochem Corp0.125SEDAR MD & ASEDAR MD & A
2023-06-29 16:54C:SBMSirona Biochem Corp0.125SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-06-28 11:28C:SBMSirona Biochem Corp0.135News ReleaseSirona develops anti-viral compounds for testing
2023-05-25 15:50C:SBMSirona Biochem Corp0.125News ReleaseSirona Biochem hires Atheln for business development
2023-05-17 20:27C:SBMSirona Biochem Corp0.13Private Placement - DebentureSirona Biochem $1,563,600 debenture private placement
2023-04-25 09:47C:SBMSirona Biochem Corp0.085News ReleaseSirona Biochem boasts of TFC-1326 trial results
2023-04-20 17:12C:SBMSirona Biochem Corp0.10News ReleaseSirona Biochem closes $1.53-million private placement